
"I want it and I want it NOW" is not always your best move. Especially with the pharmacist who is filling your Rx.

"I want it and I want it NOW" is not always your best move. Especially with the pharmacist who is filling your Rx.

How to take in the Big Picture, New Pharmacy-style.

Can you say "Risperdal," boys and girls?

Medication reconciliation, inpatient care, med safety, discharge education, transitions of care, medication adherence - these are only some of the ways pharmacists can benefit the healthcare team. There are plenty more.

Drug Topics' peripatetic pharmacist-correspondent reports from FIP 2015 in Dusseldorf.

For patients with heart failure, Entresto is the first treatment available that has been shown to decrease hospitalizations and reduce the risk of cardiovascular-related death.

CMS will now offer payers enticements to increase patient med adherence under the existing MTM model. The Part D effort is specifically focused on stand-alone Part D plans.

Venous limb gangrene can occur in cancer patients, but the clinical picture and pathogenesis aren’t clear.

A Fort Lauderdale university clinic emphasizes the connection between health, wellness, and prevention.

The pros and cons of unionizing.

Kaiser Permanente Northwest has greatly improved physician efficiency and medication accuracy – and saved the healthcare system millions of dollars - with a pharmacist-centered medication refill program.

ISMP outlines 10 precautions to follow in methotrexate dosing and administration.

The New Hampshire Board of Medicine rejected a set of rules proposed by Gov. Maggie Hassan designed to more closely regulate doctors who prescribe opioid painkillers.

Bashful customers may prefer not to discuss certain products, but they're still going to look for them on your shelves.

A new in-hospital Meijer pharmacy will be used to review medications with patients before discharge and to enroll patients in the retailer’s adherence programs.

Caremark has gained approval and the promise of tax incentives to expand its business operations near Orlando, Fla.

The Fairhaven Pharmacy in Bellingham, Washington closed its doors on Oct. 20, 2015.

Chain stores often require pharmacists to dispense 300 or more prescriptions a day. That's 37.5 Rxs an hour in an 8-hour shift or 1.6 minutes per prescription. You can't even get a doc on the phone in that amount of time.

Considerable confusion surrounds the new world of biosimilar drugs. Here are the top five issues connected with biosimilars that pharmacists should know about.

When pharmacists closely monitor patients taking new medications, patients do a better job of sticking to their regimens and overall healthcare costs decline, according to a study recently released by Walgreens.

Ohio is set to become the first state to link its prescription drug monitoring program with electronic medical records already in existence.

The number of Oklahoma residents who died last year from prescription drug overdoses dipped slightly, which some state officials believe is an indication that some of its drug-abuse prevention efforts may be succeeding.

The role of pharmacy technicians, the naming of biosimilar drugs, and the appropriate use of testosterone are the three major issues that will be discussed during the American Society of Health-System Pharmacists’ (ASHP) first virtual House of Delegates meeting.

After meeting with representatives from the American Society of Health-System Pharmacists (ASHP), the FDA recently agreed to delay enforcement of its track and trace requirements.

Tired of all those 12-hour days? If nothing else, a union will get you paid.

The American Society of Health-System Pharmacists (ASHP) offers updated guidance for pharmacists with the release of the ASHP Best Practices 2015-2016 book.

Walgreens Boots Alliance on Tuesday announced plans to acquire competitor Rite Aid for $9.4 billion. With assumed debt from Rite Aid, the deal would be worth $17.2 billion.

Earlier this month, CVS Health began offering free health screenings in 20 markets across the country as part of its annual Project Health campaign.

FDA approved idarucizumab (Praxbind), the first reversal agent for the anticoagulant dabigatran (Pradaxa) that is indicated for emergency situations when bleeding is out of control.